Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.100 | None | 1.000 | 79 | 5 | 1991 | 2019 | ||||||||
|
hypertrichosis 2 (generalized, congenital) | 0.392 | 0.808 |
|
group | 0.100 | None | 0.957 | 46 | 0 | 1999 | 2019 | |||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.923 | 39 | 0 | 1994 | 2019 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.100 | None | 0.972 | 36 | 0 | 1990 | 2017 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
group | 0.100 | None | 0.969 | 32 | 0 | 1980 | 2017 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
group | 0.100 | None | 0.964 | 28 | 0 | 1990 | 2018 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
group | 0.100 | None | 1.000 | 27 | 0 | 1996 | 2018 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.100 | None | 0.920 | 25 | 0 | 1988 | 2018 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
group | 0.100 | None | 0.960 | 25 | 0 | 1996 | 2017 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.100 | None | 0.955 | 22 | 0 | 1991 | 2017 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.100 | None | 1.000 | 21 | 0 | 1997 | 2019 | ||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
group | 0.100 | None | 1.000 | 20 | 0 | 2004 | 2019 | |||||||||
|
CD38 molecule | 0.407 | 0.885 | 2.3E-06 |
|
group | 0.100 | None | 1.000 | 20 | 0 | 1997 | 2016 | ||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
group | 0.100 | None | 1.000 | 20 | 0 | 2004 | 2019 | |||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
group | 0.100 | None | 1.000 | 20 | 0 | 1993 | 2012 | ||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
group | 0.100 | None | 0.947 | 19 | 0 | 2003 | 2019 | |||||||||
|
glutathione S-transferase theta 1 | 0.393 | 0.923 | 1.5E-04 |
|
group | 0.100 | None | 0.947 | 19 | 0 | 1996 | 2016 | ||||||||
|
immunoglobulin heavy variable 3-69-1 (pseudogene) | 0.561 | 0.654 |
|
group | 0.100 | None | 1.000 | 19 | 0 | 2004 | 2019 | |||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
group | 0.100 | None | 0.889 | 18 | 0 | 1984 | 2012 | ||||||||
|
CD6 molecule | 0.489 | 0.808 | 9.3E-05 |
|
group | 0.100 | None | 1.000 | 17 | 0 | 1988 | 2016 | ||||||||
|
zeta chain of T cell receptor associated protein kinase 70 | 0.497 | 0.769 | 0.88 |
|
group | 0.100 | None | 0.882 | 17 | 0 | 2004 | 2018 | ||||||||
|
immunoglobulin heavy variable 1-12 (pseudogene) | 0.569 | 0.654 |
|
group | 0.100 | None | 0.875 | 16 | 0 | 1984 | 2019 | |||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.100 | None | 1.000 | 16 | 0 | 2001 | 2018 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
group | 0.100 | None | 1.000 | 16 | 3 | 2004 | 2017 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
group | 0.100 | None | 0.933 | 15 | 0 | 1996 | 2015 |